iBody Inc. is a startup company from Nagoya University, Japan.

We will contribute to the improvement of human health and QOL by developing new antibody therapeutics using our unique technology "Ecobody " that can discover natural human antibodies from the human body.


25 Sep 2020

Participation in BioJapan 2020

We will participate in BioJapan2020 held in Pacifico Yokohama from 14th to 16th October 2020.

Booth : D-29,Organization for Small & Medium Enterprises and Regional Innovation, JAPAN

17 Aug 2020

Interview article introduced in Nagoya Startup News

Interview article with Yo Amakusa, CEO and Shoji Ohuchi, CSO was introduced in Nagoya Startup News.

04 Aug 2020

Patent Registered

Our unique technology for efficiently associating heavy and light chains of antibody protein in vitro has been patented in Japan. We have exclusive license agreement of this patent with Nagoya University.

03 Aug 2020


We have raised approximately 150 million yen in a third-party allotment.


Copyright ©2020 iBody Inc All Rights Reserved.